Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence to learn the language of life and transform how we treat disease. It aims to engineer the drug discovery and development process through the end-to-end application of emerging AI technologies.
- Category
- AI-driven Drug Discovery
- Stage
- Series D
- Employees
- 191
- HQ
- South San Francisco, United States
- Founded
- 2023
- Funding
- $1B